Trials / Completed
CompletedNCT00941096
Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination
Efficacy Of The Bimatoprost/Timolol Fixed Combination In Patients Treated With Bimatoprost for Primary Open Angle Glaucoma, Exfoliation Glaucoma or Ocular Hypertension.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Larissa University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the ocular hypotensive effect of Bimatoprost and the potential additional effect of the Bimatoprost/Timolol fixed combination in eyes with ocular hypertension, primary open angle glaucoma or exfoliation glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bimatoprost and Bimatoprost/Timolol fixed combination. | Following an appropriate wash-out period, participants were given a 5-week long treatment with Bimatoprost 0.03% once daily in the evening followed by a further 5-week long treatment with the Bimatoprost 0.03%/Timolol 0.5% fixed combination administered in the evening. |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2009-07-17
- Last updated
- 2010-11-30
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT00941096. Inclusion in this directory is not an endorsement.